All Industry insights December 12, 2024December 11, 2024 Unlocking the potential of AI in biologics discovery: Applications, adoption challenges, and the roadmap to success
All Company news Press releases October 1, 2024October 2, 2024 ENPICOM launches unified bioinformatics platform for lab and AI scientists
All Industry insights August 4, 2024December 23, 2024 Are your scientists making the most of your AI investment?
All Industry insights May 7, 2024December 23, 2024 Solving the data connectivity challenge to accelerate drug discovery
All Industry insights Product updates April 18, 2024September 14, 2024 Tailored workflows in discovery research: Challenges, benefits, and how to implement them today
All Industry insights March 26, 2024September 14, 2024 Reducing the barriers for immune repertoire research: An in-depth interview with Dr. Felix Breden
All Company news Press releases March 21, 2024September 13, 2024 ENPICOM secures financing from BOP Capital, BOM Brabant Ventures and brings Dr. Colby Souders on board as a new investor
All Industry insights Product updates March 4, 2024September 13, 2024 Simulating adaptive immune receptor repertoire sequencing runs with InSilicoSeq
All Company news Press releases February 20, 2024September 14, 2024 ENPICOM partners with Erasmus University Medical Center in groundbreaking effort to discover nanobodies against cancer
ENPICOM
ENPICOM Team 
Svitlana Lozova 
